Literature DB >> 27224980

Effect of Continuing Care for Cocaine Dependence on HIV Sex-Risk Behaviors.

Alexandra S Wimberly1, Megan Ivey2, Lior Rennert3, James R McKay2,4.   

Abstract

Evaluate the effect of continuing care interventions for cocaine use with HIV risk-reduction components on HIV sex-risk. Explore whether cocaine use at treatment initiation interacts with the type of continuing care intervention to affect HIV sex-risk. Cocaine dependent participants (N = 321) were randomized to: (1) Treatment as usual (TAU): intensive outpatient treatment, (2) TAU and telephone monitoring and counseling (TMC), and (3) TAU and TMC plus incentives for participation in telephone contacts (TMC+). Participants in TMC and TMC+ received a brief HIV intervention, with booster sessions as needed. Generalized estimating equations analysis compared TAU, TMC and TMC+ at 6, 12, 18, 24 months post-baseline on the following outcomes: overall HIV sex-risk, number of sexual partners, condom usage, exchange of drugs for sex, exchange of sex for drugs, exchange of money for sex, exchange of sex for money, and crack house visits. Overall sex-risk decreased for all treatment conditions at follow-up, with no treatment main effects. For people with no cocaine use at baseline, TAU experienced greater sex-risk reductions than TMC (p < .01) and TMC+ (p < .001). The three treatment conditions are effective in reducing HIV sex-risk. TMC with HIV risk-reduction components is unnecessary for cocaine-dependent clients who stop using cocaine early in treatment.

Entities:  

Keywords:  Cocaine; Continuing care; HIV; Sex-risk

Mesh:

Year:  2017        PMID: 27224980      PMCID: PMC5123976          DOI: 10.1007/s10461-016-1434-6

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  29 in total

1.  Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs.

Authors:  M L Prendergast; D Urada; D Podus
Journal:  J Consult Clin Psychol       Date:  2001-06

2.  HIV risk reduction among African-American women who inject drugs: a randomized controlled trial.

Authors:  Claire E Sterk; Katherine P Theall; Kirk W Elifson; Daniel Kidder
Journal:  AIDS Behav       Date:  2003-03

Review 3.  Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring.

Authors:  A Thomas McLellan; James R McKay; Robert Forman; John Cacciola; Jack Kemp
Journal:  Addiction       Date:  2005-04       Impact factor: 6.526

4.  Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy.

Authors:  Michael M Copenhaver; Blair T Johnson; I-Ching Lee; Jennifer J Harman; Michael P Carey
Journal:  J Subst Abuse Treat       Date:  2006-07-13

5.  Reliability of alcohol abusers' self-reports of drinking behavior.

Authors:  L C Sobell; S A Maisto; M B Sobell; A M Cooper
Journal:  Behav Res Ther       Date:  1979

6.  An adaptive approach for identifying cocaine dependent patients who benefit from extended continuing care.

Authors:  James R McKay; Deborah H A Van Horn; Kevin G Lynch; Megan Ivey; Mark S Cary; Michelle L Drapkin; Donna M Coviello; Jennifer G Plebani
Journal:  J Consult Clin Psychol       Date:  2013-09-16

7.  The role of drinking severity on sex risk behavior and HIV exposure among illicit drug users.

Authors:  Michael Scherer; Rebecca Trenz; Paul Harrell; Pia Mauro; William Latimer
Journal:  Am J Addict       Date:  2013 May-Jun

8.  Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions.

Authors:  Steffanie A Strathdee; Jamila K Stockman
Journal:  Curr HIV/AIDS Rep       Date:  2010-05       Impact factor: 5.071

Review 9.  Behavioral interventions to reduce HIV-related sexual risk behavior: review and synthesis of meta-analytic evidence.

Authors:  Seth M Noar
Journal:  AIDS Behav       Date:  2007-09-21

10.  Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group.

Authors:  M L Kamb; M Fishbein; J M Douglas; F Rhodes; J Rogers; G Bolan; J Zenilman; T Hoxworth; C K Malotte; M Iatesta; C Kent; A Lentz; S Graziano; R H Byers; T A Peterman
Journal:  JAMA       Date:  1998-10-07       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.